New device alleviates COPD symptoms
LONDON – Researchers at London’s Western University have tested the Aerobika Oscillating Positive Expiratory Pressure Therapy System and say it improves COPD therapy, reducing breathlessness in patients, product developers say. The device helped study participants more easily move mucus out of their lungs, according to developer Trudell Medical International. “Drug treatment is often the preferred method, but may not be completely effective in achieving adequate airway clearance,” said Trudell CEO Mitch Baran, in a release. “Each patient’s COPD, be it chronic bronchitis, emphysema or any other lung disease, is unique and may need a variety of therapies.” The product has regulatory approval in the U.S., Canada, Mexico and Europe.